BeStock  
Stocks › Biotechnology › IBRX

ImmunityBio IBRX

US equityMarket cap rank #1801BiotechnologyTop Gainers Yesterday
$6.02 −$0.55 (-8.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.08 +1.08%
Open$6.41
Prev close$6.57
Day range$6.00 – $6.53
Volume10.64M
Market cap$6.40B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.7x
CheapRich

Below its usual level · 28th percentile, 5-year average -5.5x

Price / book-5.6x
CheapRich

Around its usual level · 41st percentile, 5-year average -6.1x

Price / sales35.1x
CheapRich

Near the bottom of its 5-year range · 9th percentile, 5-year average 2,386.3x

#4830 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-27x-17x-8x2xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$8.95
Price vs. fair value-32.7%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -5.58 – -6.15 41% (cheaper than usual) –
PE -5.68 -15.71 -5.48 28% (cheaper than usual) –
PS 35.08 21.42 2,386.29 9% (cheaper than usual) #4830 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on IBRX.

Sign in to join the discussion.

Scroll to Top